Approach to Elevated PSA in Men with Lower Urinary Tract Symptoms

Initial Evaluation Components

The American Urological Association recommends obtaining detailed medical history focusing on the nature and duration of genitourinary symptoms, previous surgeries affecting the genitourinary tract, general health, sexual function, current medications, and fitness for potential surgical procedures 1
The International Prostate Symptom Score (I-PSS) is a validated questionnaire that assesses 3 storage symptoms (frequency, nocturia, urgency) and 4 voiding symptoms (incomplete emptying, intermittency, straining, weak stream) with an associated bother score, as recommended by the American Urological Association 1, 3
The American Urological Association suggests performing digital rectal examination (DRE) to evaluate anal sphincter tone and assess the prostate for approximate size, consistency, shape, and any abnormalities suggestive of prostate cancer 1, 2
Complete urinalysis using dipstick testing to detect hematuria, proteinuria, pyuria, or other pathological findings is recommended by the American Urological Association—if abnormal, proceed with urinary sediment examination and culture 1, 4

The American Urological Association recommends that PSA testing should only be performed if life expectancy exceeds 10 years AND a prostate cancer diagnosis would modify management 1, 5, 2
Shared decision-making discussing the risks of false-positive and false-negative results, potential complications of transrectal ultrasound-guided biopsy, and the possibility of false-negative biopsy results is essential, as suggested by the American Urological Association 1, 2

If DRE reveals suspicious findings, proceed directly to transrectal ultrasound-guided prostate biopsy regardless of PSA level, as recommended by the American Urological Association 6, 2
The American Urological Association suggests using clinical judgment to determine whether transrectal ultrasonography and biopsy are warranted if PSA is elevated above locally accepted reference range with normal DRE 1, 5

Obtaining frequency-volume charts for 3 consecutive 24-hour periods is recommended by the American Urological Association to identify nocturnal polyuria or excessive fluid intake 1, 3
The American Urological Association recommends performing uroflowmetry with at least 2 flow rate recordings before embarking on any active therapy 6, 5
Measuring post-void residual urine by transabdominal ultrasonography is suggested by the American Urological Association, repeating the test due to marked intra-individual variability 6, 5

The American Urological Association recommends considering 5α-reductase inhibitors for men with PSA >1.5 ng/mL and enlarged prostate (>30-40 cc) 6
Alpha-blockers are first-line medical therapy for bothersome voiding symptoms, regardless of prostate size, as recommended by the American Urological Association 3